BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

0
Player Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:43:54 PM : Outperform Start Price: $37.68 BMRN Score: +28.28

porto.likedded it.

Report this Post Reply

Featured Broker Partners


Advertisement